The use of gabapentin in anesthesiological practice
| dc.contributor.advisor | Szentmiklósi, József András | |
| dc.contributor.advisordept | Department of pharmacology and pharmacotherapy | hu_HU |
| dc.contributor.author | Alharthi, Saleh | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Pórszász, Róbert | |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.opponentdept | Kenézy Kórház Aneszteziológiai és Intenziv Therápiás Osztály | hu_HU |
| dc.date.accessioned | 2017-08-23T06:52:08Z | |
| dc.date.available | 2017-08-23T06:52:08Z | |
| dc.date.created | 2017-05-26 | |
| dc.description.abstract | Gabapentin is a structural analogue of gamma amino butyric acid (GABA),As this carrier-dependent transport is saturable, the bioavailability of gabapentin varies inversely with dose.it is thought to exert its action by interaction with a receptor associated with the L-system amino acid carrier protein.. Gabapentin has proved to be efficacious as an adjunct to other anticonvulsants in the treatment of partial seizures and generalised tonic-clonic seizures in patients over 12 years of age | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 35 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/243089 | |
| dc.language.iso | en | hu_HU |
| dc.subject | gabapentin | hu_HU |
| dc.subject | anesthesiology | |
| dc.subject | pharmacology | |
| dc.subject | pharmacotherapy | |
| dc.subject.dspace | DEENK Témalista::Orvostudomány::Farmakológia | hu_HU |
| dc.title | The use of gabapentin in anesthesiological practice | hu_HU |